Amyris has entered a deal for the sale of convertible notes in a private placement for up to $60 million in cash proceeds. Amyris’s largest stockholders, Temasek, agreed to purchase $35 million of the notes in an initial tranche and, at Amyris’s election, up to $25 million in a second tranche. Both tranches are subject to Amyris’s satisfaction of closing conditions, including stockholder approval of the transaction at an upcoming special meeting of stockholders.
FOLLOW ME ON THESE SPACE
Discussion
Comments are closed.